Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Susie924 who wrote (73031)	12/1/2000 5:20:09 PM
From: Bidder	Respond to of 150070

Related Quotes VITC.OB 0.150000 +0.050000 delayed 20 mins - disclaimer Thursday November 30, 1:12 pm Eastern Time Press Release SOURCE: VersaTech, Inc. VersaTech, Inc., Improves Packaging and Launches New Website HAWLEY, Pa., Nov. 30 /PRNewswire/ -- Universal Network Inc., a subsidiary of VersaTech, Inc. (OTC Bulletin Board: VITC - news) today announced that it is launching a new Web site, tryuni.com, to promote its flagship product Unitropin® (hGH Formula Plus), as well as its other health and beauty aid product lines. In addition, although the successful Unitropin formula will remain unchanged, the company has improved the dosage form and the product packaging in ways that are designed to appeal to both consumers and retailers. ``We are very pleased to have resolved the packaging problems that hindered us last year,'' said Ron Meredith, president of Universal Network. ``The new capsule formulation has advantages for both consumers and retailers. It is easier to swallow than the previous tablet dosage form, and from a business perspective the packing is smaller which makes for improved shipping, handling and warehousing, and reducing retail shelf space for retailers,'' he continued. Timed to coincide with the new Unitropin dosage form and packaging is the launch of the TryUni Web site, which is designed to incentivize people to use the product and grow the Unitropin autoship customer base. ``When a customer orders their initial package of Unitropin through the TryUni site and signs up for the autoship program, they also instantly get their own Web site that they can use as a storefront to promote Unitropin to other people without ever leaving their home,'' said Ron Meredith. ``We found that many people were so enthusiastic about the product that they were already promoting Unitropin to others, so we wanted to give them an organized way to benefit from their word-of-mouth,'' added Meredith. ``It's been a long road through our restructuring period,'' said Michael Daily, President of VersaTech, Inc., ``but sales and revenue expectations are high as we finish up the year and move into 2001.'' ``In the near future we plan to expand our marketing efforts around Unitropin and to broaden our product line and revenue sources,'' added Daily. More information can be found at the company Web sites: versatechinc.com tryuni.com unitropin.com longerliving.com VersaTech, Inc. is publicly traded on the OTC Bulletin Board under the symbol ``VITC.'' For more information contact Steve Krakonchuk 888-222-9293 or 604-214-9392 and visit the VersaTech corporate Web site at versatechinc.com. CONTACT: Steve Krakonchuk of VersaTech, 888-222-9293, or 604-214-9392. SOURCE: VersaTech, Inc. Email this story - Most-emailed articles - Most-viewed articles -------------------------------------------------------------------------------- More Quotes and News: VersaTech Inc (OTC BB:VITC.OB - news) Related News Categories: computers, internet -------------------------------------------------------------------------------- Help -------------------------------------------------------------------------------- Copyright © 2000 Yahoo! Inc. All rights reserved.Privacy Policy - Terms of Service Copyright 2000 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Questions or Comments?